Case Western Reserve University has been awarded by Advanced Research Projects Agency for Health (ARPA-H) to develop and commercialize “live” joints to address debilitating and chronic illness, known as osteoarthritis (OA). This project is supported by ARPA-H’s Novel Innovations for Tissue Regeneration in Osteoarthritis (NITRO) program.
The innovative project, titled OMEGA: Orchestrating Multifaceted Engineering for Growing Artificial Joints, aims to revolutionize traditional treatments for osteoarthritis through groundbreaking advancements of cell regeneration. These biologically engineered joints will restore function and improve long-term quality of life for those living with OA.
With the expertise and knowledge of researchers, scientists, engineers and healthcare providers, the OMEGA project is committed to transforming the future of OA treatments to improve the mobility and independence of individuals living with this degenerative disease.
Health Engagement and Accessibility
The OMEGA Engagement and Accessibility team aims to reduce health disparities and improve health outcomes in all individuals by emphasizing the importance of accessible and equitable healthcare throughout the entirety of this project.
Meet the Engagement and Accessibility Team
Engagement Advisory Committee
The Engagement Advisory Committee is composed of community leaders, influencers, and residents who are committed to advancing health equity to promote better health outcomes. The members possess a wide array of skills and expertise related to osteoarthritis, community engagement and advocacy.
Learn About the Engagement Advisory Committee
Involvement Opportunities
To ensure that all voices from the community are heard, OMEGA Engagement and Accessibility offers various platforms where individuals are able to share their experiences living with chronic knee pain or osteoarthritis of the knee.